Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children

Journal of Virology

Volumn 75, Issue 10, 2001, Pages 4941-4946

  Buseyne, F ^a   Chaix, M L ^a   Rouzioux, C ^a   Blanche, S ^a   Riviere Y ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EPITOPE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LAMIVUDINE; MUTANT PROTEIN; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

CHILD; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HLA-B ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC; VARIATION (GENETICS);

EID: 0035037330     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.10.4941-4946.2001     Document Type: Article

References (28)

1. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians
2. Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires
3. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection
4. Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children
5. Cross-clade-specific cytotoxic T lymphocytes in HIV-1 infected children
6. Multi-specific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: Factors other than the MHC control the epitopic specificities
7. gag protein
8. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development
9. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles
10. Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa
11. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients
12. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers
13. Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A*0201 + cytotoxic T cell line
14. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection
15. Immune correlates of protection from HIV infection and AIDS
16. AIDS and HIV vaccines
17. Progress in the development of an HIV-1 vaccine
18. Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais
19. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection
20. Understanding the genetic diversity of HIV-1
21. HIV-1 nomenclature proposal
22. Recombination in HIV-1
23. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
24. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules
25. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53
26. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: Implications for vaccine development
27. Cross-clade envelope glycoprotein 160-specific CD8(+) cytotoxic T lymphocyte responses in early HIV type 1 clade B infection